Axon Enterprise (AXON) drops 8.21% to 52-week low of $396.41. Legal risks from Scottsdale HQ lawsuits and analyst cuts pressure the stock.
Browsing: News
Dollar Tree (DLTR) stock fell 5% Tuesday amid analyst price target cuts and inflation worries. The discount retailer’s cautious 2026 outlook continues to weigh.
Oil prices surge past $116 per barrel after US strikes Iran’s Kharg Island export terminal. Trump sets evening deadline as Tehran rejects ceasefire terms.
Apple (AAPL) shares declined 4.3% following reports that engineering issues may delay its foldable iPhone launch by months beyond the planned 2026 release.
Paramount Skydance (PSKY) stock rises 8% after securing $47B PIPE financing backed by Middle East sovereign wealth funds for WBD acquisition.
Delta Air Lines (DAL) stock slipped 2% after announcing a $10 increase in checked bag fees, the first domestic hike in two years due to rising fuel costs.
CVS Health (CVS) stock jumped 5% after CMS approved a 2.48% Medicare Advantage payment increase, adding over $13B in funding for 2027.
Cemtrex (CETX) stock doubled after subsidiary Invocon won a Phase I U.S. Navy SBIR contract for modular mine warfare components. Shares jumped 100%+.
Microsoft (MSFT) trades 31% below its peak at $371.71. Major Wall Street firms see 56-60% upside with $600 targets despite AI spending concerns.
Uber (UBER) expands AWS partnership, deploying Amazon’s Graviton4 for ride-matching and Trainium3 for AI training to improve speed and cut costs.
Nvidia (NVDA) generated $215.9B vs AMD’s $34.6B. Compare their data center revenue, margins, and export risks in this comprehensive AI chip stock analysis.
Intel (INTC) stock rises ~2% after joining Elon Musk’s Terafab chip venture with SpaceX, xAI, and Tesla to deliver 1 terawatt of AI compute annually.
Gilead Sciences (GILD) to acquire Tubulis for $5B, strengthening cancer drug pipeline. RBC raises target to $123 ahead of Q1 earnings on April 23.
DoorDash (DASH) director sells $3.47M in shares as insiders offload $18.3M. Stock down 45% from highs despite analyst Buy ratings and $263 price target.
UnitedHealth (UNH) stock gains after Medicare Advantage rates increase 2.48% for 2027, beating expectations and offering relief to the healthcare giant.